HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $17 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Patrick Trucchio reiterated a Buy rating on Precision BioSciences (NASDAQ:DTIL) and maintained a $17 price target.
June 01, 2023 | 2:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Patrick Trucchio reiterated a Buy rating on Precision BioSciences and maintained a $17 price target.
The reiteration of a Buy rating and maintenance of a $17 price target by HC Wainwright & Co. analyst Patrick Trucchio indicates a positive outlook for Precision BioSciences (NASDAQ:DTIL) in the short term. This news is directly related to the company and is important for investors as it reflects the analyst's confidence in the stock's potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100